Trending Stocks: Gilead Sciences, (GILD), Apple (AAPL), Celldex Therapeutics, (CLDX), Alibaba Group Holding (BABA)

US stocks fell sharply Monday, led by declines in energy stocks as the price of oil plunged again. The euro sank to a nine-year low against the dollar as new doubts surfaced about Greece's future in the common currency bloc.

ENERGY: Oil prices extended a slide that began in June last year. Benchmark U.S. crude was down $2.50 at $50.16 a barrel on the New York Mercantile Exchange. The price fell as low as $49.95. The contract dropped 58 cents to $52.69 on Friday. Oil is down from $107 a barrel in June as global demand slackened while supplies remained high.

Energy stocks led declines in the S&P 500, dropping 4 percent. Chevron fell $4.9, or 4.3 percent, to $107.72 and Exxon Mobil dropped $2.90, or 3.1 percent, to $89.92. {1}

Gilead Sciences, (NASDAQ:GILD) closed higher 2.34% to $97.07, recently declared an expansion to its contract with Janssen R&D Ireland for the development and commercialization of a new once-daily single tablet regimen containing Gilead’s tenofovir alafenamide (TAF) and emtricitabine, and Janssen’s rilpivirine. The original contract was established in 2009 for the development and commercialization of Complera®, marketed as Eviplera® in the European Union, which combines tenofovir disoproxil fumarate, emtricitabine and rilpivirine in a once-daily tablet.

Apple (NASDAQ:AAPL) closed lower -2.50% to $106.62, declared that models of iPad Air™ 2 and iPad mini™ 3 with cellular networking will be available in China recently. TD-LTE and FDD-LTE standards, as well as TD-SCDMA, DC-HSDPA, HSPA+ and other fast networks, are all available in a single model, giving iPad Air 2 consumers in China the ability to stay connected on advanced cellular data networks in China and around the world so they can go more places and do more things.

Celldex Therapeutics, (NASDAQ:CLDX) closed gained 5.00% to $19.19, declared the appointment of Richard A. van den Broek to the organization's Board of Directors. Mr. van den Broek currently serves as a Managing Partner of HSMR Advisors, LLC, an investment fund focused on the biotechnology industry. In addition, the organization declared that Timothy Shannon, MD has resigned from the Board due to demands on his time, including his roles as Chairman of the Board of Directors of Arvinas, Inc., a privately held biotechnology company and as a General Partner at Canaan Partners.

Alibaba Group Holding (NYSE:BABA) closed declined -2.78% to $100.72, The organization through its subsidiaries, operates as an online and mobile commerce organization  in the People’s Republic of China and internationally. It operates Taobao Marketplace, an online shopping destination; Tmall, a third-party platform for brands and retailers; Juhuasuan, a group buying marketplace; Alibaba.com, an online business-to-business marketplace that focuses on global trade among businesses; 1688.com, an online wholesale marketplace; and AliExpress, a consumer marketplace.

Source{1}: http://seattletimes.com/html/businesstechnology/2025386078_apxfinancialmarkets.html